Yes, baseline testing of IGF-1, complete blood count, comprehensive metabolic panel, and relevant hormones helps assess response and adjust dosing. For GH-releasing peptides, pre and post IGF-1 levels confirm efficacy. For healing peptides, inflammation markers like CRP can track progress. Recommendations from
Endocrine Practice emphasize baseline and follow-up testing to optimize dosing and monitor for any adverse metabolic effects.